Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02164838
Title VEGF Receptor Tyrosine Kinase Inhibitor Axitinib in Children With Recurrent or Refractory Solid Tumors
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements No
Sponsors Children's Oncology Group
Indications

renal cell carcinoma

Advanced Solid Tumor

Therapies

Axitinib

Age Groups: child
Covered Countries USA | CAN


No variant requirements are available.